These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6776564)

  • 1. The effects of thyrotropin-releasing hormone on the central nervous system responses to chronic morphine administration.
    Bhargava HN
    Psychopharmacology (Berl); 1980; 68(2):185-9. PubMed ID: 6776564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome.
    Bhargava HN; Matwyshyn GA
    Psychopharmacology (Berl); 1985; 87(2):141-6. PubMed ID: 2996045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid induction and quantitation of morphine dependence in the rat by pellet implantation.
    Bhargava HN
    Psychopharmacology (Berl); 1977 Mar; 52(1):55-62. PubMed ID: 403558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
    Way EL; Iwamoto ET; Khanna S; Ho IK; Shen F; Loh HH
    J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome.
    Bhargava HN; Thorat SN
    Pharmacology; 1996 Feb; 52(2):86-91. PubMed ID: 8851629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice.
    Ballard TM; McAllister KH
    Pharmacol Biochem Behav; 1999 Feb; 62(2):285-90. PubMed ID: 9972695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of thyrotropin releasing hormone and morphine on gastrointestinal transit.
    Pillai NP; Bhargava HN
    Peptides; 1984; 5(6):1055-9. PubMed ID: 6099556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pargyline on morphine tolerance and physical dependence development in mice.
    Iwamoto ET; Ho IK; Way EL
    Eur J Pharmacol; 1976 Aug; 38(2):261-8. PubMed ID: 986307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
    Bhargava HN; Das S; Bansinath M; Prasad R
    Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracisternal administration of interleukin-1 beta attenuates naloxone-precipitated withdrawal in morphine-dependent mice.
    Katsumata S; Minami M; Nakagawa T; Satoh M
    Eur J Pharmacol; 1995 May; 278(2):143-50. PubMed ID: 7671998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
    Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
    Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
    Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of NG-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice.
    Thorat SN; Barjavel MJ; Matwyshyn GA; Bhargava HN
    Brain Res; 1994 Apr; 642(1-2):153-9. PubMed ID: 7518322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
    Fdez Espejo E; Cador M; Stinus L
    Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.
    Bhargava HN
    Psychopharmacology (Berl); 1976 Sep; 49(3):267-70. PubMed ID: 826944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
    Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
    Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of naltrexone on the development of physical dependence on morphine.
    Bhargava HN
    Eur J Pharmacol; 1978 Aug; 50(3):193-202. PubMed ID: 567585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome.
    Bhargava HN
    Pharmacol Biochem Behav; 1978 Jan; 8(1):7-11. PubMed ID: 564515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of narcotic tolerance and physical dependence: effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly).
    Bhargava HN; Walter R; Ritzmann RF
    Pharmacol Biochem Behav; 1980 Jan; 12(1):73-7. PubMed ID: 6102769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.